Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
Article in The Lancet Respiratory Medicine (July 2021)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Genetic alteration profile of EGFR -mutant resected IIB–IIIA stage NSCLC and correlation to clinical outcomes
Article in Translational Lung Cancer Research (December 2019)
The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?
Article in Annals of Translational Medicine (February 2017)